Cerus Corporation (CERS)
NASDAQ: CERS · Real-Time Price · USD
3.210
+0.030 (0.94%)
At close: Jul 16, 2026, 4:00 PM EDT
3.210
0.00 (0.00%)
After-hours: Jul 16, 2026, 4:38 PM EDT

Cerus Revenue

Cerus had revenue of $59.89M in the quarter ending March 31, 2026, with 22.60% growth. This brings the company's revenue in the last twelve months to $244.84M, up 18.41% year-over-year. In the year 2025, Cerus had annual revenue of $233.80M with 16.13% growth.

Revenue (ttm)
$244.84M
Revenue Growth
+18.41%
P/S Ratio
2.97
Revenue / Employee
$787,473
Employees
275
Market Cap
643.18M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025233.80M32.48M16.13%
Dec 31, 2024201.32M14.52M7.78%
Dec 31, 2023186.80M-1.52M-0.81%
Dec 31, 2022188.32M28.80M18.05%
Dec 31, 2021159.52M45.27M39.62%
Dec 31, 2020114.25M20.48M21.83%
Dec 31, 201993.77M17.72M23.30%
Dec 31, 201876.05M24.73M48.17%
Dec 31, 201751.33M12.05M30.68%
Dec 31, 201639.28M5.05M14.76%
Dec 31, 201534.22M-2.19M-6.02%
Dec 31, 201436.42M-3.24M-8.17%
Dec 31, 201339.66M2.87M7.80%
Dec 31, 201236.79M3.74M11.32%
Dec 31, 201133.04M9.94M42.99%
Dec 31, 201023.11M5.13M28.51%
Dec 31, 200917.98M1.48M8.94%
Dec 31, 200816.51M5.46M49.47%
Dec 31, 200711.04M-19.27M-63.56%
Dec 31, 200630.31M16.81M124.57%
Dec 31, 200513.50M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Orthofix Medical825.37M
Tactile Systems Technology343.52M
Viemed Healthcare286.57M
OrthoPediatrics243.30M
SI-BONE206.22M
Cytek Biosciences204.17M
Beta Bionics110.24M
NeuroPace99.53M
Revenue Rankings